MindMaze, a SaaS-based digital neurotherapeutics and telerehabilitation platform, announced the closing of a $125 million funding round.
The financing was provided by AlbaCore Capital Group, Europen specialist investors focusing on public and private corporate credit markets.
MindMaze plans to use the latest proceeds to accelerate commercialization and enhance market access for its approved and reimbursed neuro-rehabilitation platform, particularly in North America and Europe.
The funds will also be used to expand its SaaS-based digital neurotherapeutics platform and expand its neuro-restorative portfolio through further system development and clinical trials in additional indications, including acute stroke, Parkinson’s disease, Alzheimer’s disease, traumatic brain injury, multiple sclerosis, and aging.
MindMaze offers a digital neurotherapeutics platform, delivering seamless digital assessments and therapeutics for thousands of patients suffering from neurological conditions. The Company currently collaborates with approximately ninety healthcare providers and has a product portfolio that has received three FDA clearances and four CE marks across eight clinical indications.
According to MindMaze, its digital neurotherapeutics platform combines engaging, personalized, protocolized, quantified, gamified digital therapeutic content supported by tailored peripherals that target two distinct areas of care: neuro-rehabilitation and neuro-restoration.
“MindMaze is dedicated to improving the lives of patients around the world through the development of novel digital therapeutic products for the treatment of serious neurological conditions. We have built the leading neuro-focused digital health platform comprehensively addressing full-body motor and cognitive challenges associated with critical neurological conditions. We believe that the demands of a rapidly aging world population make our proprietary, proven solutions more critical now than ever before,” stated Tej Tadi, Ph.D., MindMaze founder, and CEO.
Digital Health companies raised nearly $15 billion in the first half of 2021, according to the latest Mercom Digital Health Funding and M&A Report.